title: [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
abstract: Two cases of hyperglycemia complicating therapy of childhood ALL with the use of L-asparaginase are described. Both patients required insulin administration. The relationship between L-aspa therapy and clinical manifestation of hyperglycemia seems to indicate that this could be the side effects of the drug.
authors.affiliation: I Kliniki Chorób Dzieci Katedry Chorób Dzieci PAM w Szczecinie.
authors.forename: A
authors.initials: A
authors.lastname: Brodkiewicz
authors.forename: E
authors.initials: E
authors.lastname: Kamieńska
authors.forename: T
authors.initials: T
authors.lastname: Urasiński
authors.forename: J
authors.initials: J
authors.lastname: Peregud-Pogorzelski
mesh_terms: D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D001215:Asparaginase
vernacular_title: Hiperglikemia jako powikłanie stosowania L-asparaginazy u dzieci z ostra białaczka limfoblastyczna (OBL).